Objective: To describe the clinical presentation, management, and treatment outcomes of Mooren’s ulcer
Methods: We reviewed records of all patients diagnosed with Mooren’s ulcer at Ruharo Eye Centre
from January 2013 to December 2015. We collected data from fifty-two patient charts on demographic
characteristics, history and presenting complaints, eye affected, clinical presentation, modes of medical
and surgical treatment, and post treatment visual acuity.
Results: The median age was 24.5 years (IQR 16.5 years). The ratio of males to females was 8:1. Thirty two
(82.1%) patients presented with pain, 13 (33.3%) with redness, and 10 (25.7%) with tearing. Forty seven
(90.4%) patients had unilateral disease. Four (80%) of those with bilateral disease were aged 30 years and
above while one (20%) was below 30 years. Twenty nine (55.8%) of the patients received only medical
treatment and 23 (44.2%) received various forms of surgical management. Forty one (78.8%) still had
active ulceration on their last review date, 7 (13.5%) perforated after admission, 3 (5.8%) of the patients
were marked as healed on their last review date, and one (1.92%) was eviscerated. At the last follow up,
most patients ended with worse visual acuity (n=21, 40.4%) while 20 (38.5%) had no change and only 11
Conclusion: This primary study provided background information on presentation of Mooren’s ulcer in
Uganda; our data indicated that younger males were the most affected group; severe disease occurred in
Chen J, Xie H, Wang Z, Yang B, Liu Z, Chen L,
et al. Mooren’s ulcer in China: a study of clinical
characteristics and treatment. Br J Ophthalmol.
Foster CS, Kenyon KR, Greiner J. The
immunopathology of Mooren’s ulcer. Amer J
Ophthalmol. 1979; 88 (2): 149-159.
Schallenberg M, Westekemper H, Steuhl K,
Meller D. Amniotic membrane transplantation
ineffective as additional therapy in patients with
aggressive Mooren’s ulcer. BMC Ophthalmol.
Taylor C, Smith S, Morgan C, Stephenson S,
Key T, Srinivasan M, et al. HLA and Mooren’s
ulceration. Br J Ophthalmol. 2000; 84(1): 72-75.
Sangwan VS, Zafirakis P, Foster C. Mooren’s
ulcer: Current concepts in management. Curr
Ophthalmol. 1997; 45(1):7-17.
Hwang FS, Sirajeldin A. Mooren’s Ulcer.
American Academy of Ophthalmology; 2015
[updated 04/08/2015; cited 2016 25/01/2016];
Available from: http://eyewiki.aao.org/Mooren’s_Ulcer.
Sangwan VS, Zafirakis P, Foster CS. Mooren’s
ulcer: Current concepts in management. Indian J
Ophthalmol. 1997; 45 (1): 7-17.
Abah ER, Akinwande AO, Pam VA. Mooren’s
corneal ulceration in a pseudophakic eye: A case
report and literature review. Annals Nigerian Med.
; 6(1): 50.
Al Motowa S, Al Zobidi M. Amniotic membrane
transplant with a special technique (Motowa’s
Sandwich Technique) in Mooren’s ulcer. Middle
East Afr J Ophthalmol. 2015; 22(3): 386-388.
Fasina O, Ogundipe A, Ezichi E. Mooren’S ulcer
in ibadan, southwest Nigeria. J West Afr Coll Surg.
; 3(3): 102-119.
Lewallen S, Courtright P. Problems with current
concepts of the epidemiology of Mooren’s corneal
ulcer: Annals Ophthalmol. 1990; 22(2) 52-55. 62.
Bhandari V, Siddharthan KS. Bilateral Mooren’s
ulcer - Customised corneal graft with additional
amniotic membrane graft. Saudi J Ophthalmol.
; 29(3): 235-237.
Kietzman B. Mooren’s ulcer in Nigeria. Amer J
Ophthalmol. 1968; 65(5): 679-685.
Srinivasan M, Zegans ME, Zelefsky JR,
Kundu A, Lietman T, Whitcher JP, et al. Clinical
characteristics of Mooren’s ulcer in South
India. [Editorial]: Br J Ophthalmol. 2007;